Literature DB >> 11600487

Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.

W E Severus1, A B Littman, A L Stoll.   

Abstract

Depression is associated with elevated rates of cardiovascular morbidity and mortality. This elevation seems to be due to a significantly increased risk of coronary artery disease and myocardial infarction and, once the ischemic heart disease is established, sudden cardiac death. Recent data suggest that the increased rates of cardiovascular disease in patients with depression may be the result of one or more still-unrecognized underlying physiological factors that predispose a patient to both depression and cardiovascular disease. Two possibly related factors that may have a causal relation with both depressive disorders and cardiovascular disease are an omega-3 fatty acid deficiency and elevated homocysteine levels. We present the available data connecting cardiovascular disease, depression, omega-3 fatty acids, and homocysteine. In addition, we suggest research strategies and some preliminary treatment recommendations that may reduce the increased risk of cardiovascular mortality in patients with major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600487     DOI: 10.1080/10673220127910

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  19 in total

Review 1.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

Review 2.  Emerging risk factors for postpartum depression: serotonin transporter genotype and omega-3 fatty acid status.

Authors:  Gabriel D Shapiro; William D Fraser; Jean R Séguin
Journal:  Can J Psychiatry       Date:  2012-11       Impact factor: 4.356

3.  Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Phyllis K Stein; Brian C Steinmeyer; William S Harris; Eugene H Rubin; Ronald J Krone; Michael W Rich
Journal:  Psychosom Med       Date:  2010-08-17       Impact factor: 4.312

4.  Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study.

Authors:  Johanna Assies; François Pouwer; Anja Lok; Roel J T Mocking; Claudi L H Bockting; Ieke Visser; Nico G G M Abeling; Marinus Duran; Aart H Schene
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

Review 5.  [The influence of diet on mental health].

Authors:  C Hausteiner; S Bornschein; T Zilker; H Förstl; J Grassmann
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

6.  Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Authors:  Robert M Carney; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; Brian C Steinmeyer; William S Harris
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

7.  Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels.

Authors:  Alpesh A Amin; Rishi A Menon; Kimberly J Reid; William S Harris; John A Spertus
Journal:  Psychosom Med       Date:  2008-10-08       Impact factor: 4.312

Review 8.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

9.  Relationship between depression and apolipoproteins A and B: a case-control study.

Authors:  Masoumeh Sadeghi; Hamidreza Roohafza; Hamid Afshar; Fereshteh Rajabi; Mohamadarash Ramzani; Hasan Shemirani; Nizal Sarafzadeghan
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.